4.7 Article

Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers

Journal

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Volume 76, Issue 9, Pages 2294-2301

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkab170

Keywords

-

Funding

  1. Ministry of Research and Innovation within Program 1-Development of the national RD system, Subprogram 1.2-Institutional Performance-RDI excellence funding projects [PFE 23/2018]
  2. University Paris-Saclay
  3. AP-HP Paris-Saclay
  4. Institut National de la Sante et de la Recherche Medicale (INSERM)
  5. Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT)
  6. French National Research Agency [ANR-10-LABX-33]

Ask authors/readers for more resources

The rCIM-A can effectively differentiate between AHEs and CPEs, with a sensitivity of 84.26% and specificity of 99.29%. While it has limitations in detecting certain resistance mechanisms, it can serve as a simple, fast, and accurate method for CPE detection.
Objectives: Detection of carbapenemase-producing Enterobacterales (CPEs) is sometimes difficult with AmpC-hyperproducing Enterobacterales (AHEs), as they may falsely be classified as CPEs. Here, we present a rapid Carbapenem Inactivation Method (rCIM) optimized for AmpC producers (rCIM-A) that allows rapid and easy discrimination between AHEs and CPEs. Methods: Enterobacterales (n = 249), including natural AmpC producers, AHEs, CPEs and non-carbapenemase-producing carbapenem-resistant control strains were evaluated, using Carba NP, rCIM and rCIM-A. The rCIM-A differs from the rCIM by the addition of cloxacillin (400 mu g/mL) to the initial antibiotic incubation step. Results: The rCIM-A yielded a sensitivity and specificity of 84.26% (95% CI: 76.00%-90.55%) and 99.29% (95% CI: 96.11%-99.98%), respectively, while those of the rCIM were 86.11% (95% CI: 78.13%-92.01%) and 80.85% (95% CI: 73.38%-86.99%), respectively; those of Carba NP were Lower at 84.04% (95% CI: 75.05%-90.78%) and 91.37% (95% CI: 85.41%-95.46%), respectively, due to indeterminate results. The rCIM-A was capable of discriminating between AHEs and true CPEs, but still failed to identify OXA-23-producing Proteus mirabilis isolates and remained only partially reliable for identifying IMI-Like producers and a few MBL (2 NDM-1, 1 LMB-1, 1 TMB-1 and 1 IMP-13) producers. One chromosomally encoded AmpC variant, MIR-10, gave repeatedly positive results using all three tests and was thus considered a false positive. Conclusions: Specificity for AHEs greatly improved with the rCIM-A without altering the test performance for the other resistance mechanisms. It may replace the rCIM as a cheap, easy, rapid and accurate CPE detection test.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available